Showing results (741-750 of 835) with videos related to
Sort By:
Pageof 84
Science Advances|November 13, 2024
Channel width modulates the permeability of DNA origami-based nuclear pore mimicsQingzhou Feng, Martin Saladin, Chunxiang Wu, et al.Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing programMalcolm A Smith, C Patrick Reynolds, Min H Kang, et al.Elife|June 4, 2019
Age-dependent deterioration of nuclear pore assembly in mitotic cells decreases transport dynamicsIrina L Rempel, Matthew M Crane, David J Thaller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman, Kristine R Crews, Catherine Billups, et al.Pediatric Blood & Cancer|October 21, 2011
Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Gorlick, et al.Ecology and Evolution|December 22, 2025
Testing the Sentinel Method: Live and Artificial Prey Display Contrasting Patterns of Predation Across an Urban GradientYu Zeng, Haolin Yang, Yiheng Pan, et al.Pediatric Blood & Cancer|January 23, 2016
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing ProgramRichard Gorlick, E Anders Kolb, Stephen T Keir, et al.Cell Reports|June 22, 2017
Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresRebecca A Dagg, Hilda A Pickett, Axel A Neumann, et al.Pageof 84